Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000568104

Apexbio Technology LLC FHD-286-25MG
SDP

Catalog No. 5000568104
Encompass_Preferred

FHD-286 (CAS No 2671128-05-3) is a novel compound in the field of biomedical research primarily categorized under oncology Originally developed from a series of studies exploring targeted cancer therapies FHD-286 acts by inhibiting specific signaling pathways that are crucial for tumor cell proliferation and survival It exhibits potent activity within the nanomolar to low micromolar range making it a valuable tool for in vitro experiments Common applications include its use in various cell models such as breast and lung cancer cells as well as in vivo studies involving xenograft models in mice Additionally FHD-286 is frequently utilized in drug screening programs focused on identifying new therapeutic agents against resistant cancer types Experimental concentrations are typically dependent on the specific research design allowing for tailored applications in diverse experimental settings

Catalog No. 50-005-68104 Supplier Apexbio Technology LLC Supplier No. BA465825
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

FHD-286 (CAS No 2671128-05-3) is a novel compound in the field of biomedical research primarily categorized under oncology Originally developed from a series of studies exploring targeted cancer therapies FHD-286 acts by inhibiting specific signaling pathways that are crucial for tumor cell proliferation and survival It exhibits potent activity within the nanomolar to low micromolar range making it a valuable tool for in vitro experiments Common applications include its use in various cell models such as breast and lung cancer cells as well as in vivo studies involving xenograft models in mice Additionally FHD-286 is frequently utilized in drug screening programs focused on identifying new therapeutic agents against resistant cancer types Experimental concentrations are typically dependent on the specific research design allowing for tailored applications in diverse experimental settings

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.